• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Horizon Discovery

edit

Horizon Discovery (Horizon) is striving to provide researchers with the gold-standard tools that will accelerate the search for new and effective ‘targeted’ or ‘personalised’ medicines.

Central to realizing this ambition is the deployment of a proprietary gene-engineering technology called GENESIS that enables any endogenous gene in a human cell-line to be altered quickly, reliably and without introducing unwanted and confounding genotypes and/or phenotypes.

Recent Milestones

edit

• 
  Horizon Discovery received $18.6M in Series C funding. (1/16/12)
  Posted 1/15/12 at 11:46pm via onbiovc.com
• 
  Horizon Discovery received $11.1M (£7M) in Venture Round funding. (9/13/11)
  Posted 10/21/11 at 12:02am
• 
  Horizon Discovery received $9.8M in Series C funding. (9/28/10)
  Posted 9/28/10 at 8:12pm via dowjones.com
• 
  Horizon Discovery received $298k in Series A funding. (4/7/08)
  Posted 6/8/09 at 10:45pm
• 
  Horizon Discovery added Chris Torrance as CEO.
  Posted 6/8/09 at 10:45pm
• 
  Horizon Discovery added Darrin M Disley as Executive Chairman.
  Posted 6/8/09 at 10:45pm
• 
  Horizon Discovery added Paul Morrill as Business Development.
  Posted 8/17/10 at 4:55am

Videos

Screenshots

edit

Above: Horizon Discovery Homepage
Uploaded: 8/17/10

Sources

1. Capital Funding Report [edit]
2. Horizon Discovery Raises $9.8M For Genetic Modeling (fis.dowjones.com) [edit]
3. EDGAR [edit]
4. Horizon Discovery, Ltd.: Series C $18.6M (onbiovc.com) [edit]